Catalyst Wire Dossier Catalyst Wire Dossier

BPS804

· Ultragenyx Pharmaceutical Inc
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BPS804, covering 2021-05-11 to 2022-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation Study to Evaluate the Safety and Tolerability of Multiple Infusions of BPS804 in Adults With Hypophosphatasia (HPP) [Phase 2]

See pricing